$WVE

$3.40▼ -78.68% YTD

9 SEC 13D/G filings tracked · Last updated Oct 27, 2026

Filing History

WVE - Wave Life Sciences, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified

$3.40▼ -78.68%Oct 27, 2026 · ThinkSabio Blog

$WVE SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #WVE Wave Life Sciences, Inc. : $3.40 Sector: Healthcare | YTD: 🔽…

News

WVE ▲ +7.1% - Wave Life Sciences, Inc.

CP $3.45▲ +7.1%Oct 27, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update…

News

WVE ▲ +0.9% - Wave Life Sciences, Inc.

CP $3.20▲ +0.9%Oct 20, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026…

News

WVE ▲ +2.9% - Wave Life Sciences, Inc.

CP $3.22▲ +2.9%Oct 19, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026…

News

WVE ▼ -0.6% - Wave Life Sciences, Inc.

CP $3.26▲ -0.6%Oct 13, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference…

News

WVE ▲ +0.3% - Wave Life Sciences, Inc.

CP $3.71▲ +0.3%Oct 1, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD…

News

WVE ▲ +1.9% - Wave Life Sciences, Inc.

CP $3.71▲ +1.9%Sep 30, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development…

News

WVE ▲ +0.7% - Wave Life Sciences, Inc.

CP $4.38▲ +0.7%Sep 23, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity…

News

WVE ▼ -3.7% - Wave Life Sciences, Inc.

CP $4.70▲ -3.7%Sep 3, 2026 · ThinkSabio Blog

$WVE - Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference…